tripelennamine has been researched along with Symptom Cluster in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mair, TS | 1 |
Howarth, S | 1 |
Lane, JG | 1 |
1 trial available for tripelennamine and Symptom Cluster
Article | Year |
---|---|
Evaluation of some prophylactic therapies for the idiopathic headshaker syndrome.
Topics: Administration, Inhalation; Administration, Intranasal; Animals; Anti-Asthmatic Agents; Anti-Inflamm | 1992 |